Skip to main content

Envista Holdings Corp

corporate_fare Company Profile

Envista Holdings Corp

NVST·NYSE·Industrial Applications And Services·CIK 0001757073

Envista is a global dental products company with over 30 dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr. The company provides industry-leading products, solutions, and technology to dental professionals to support patient care. Its portfolio includes dental implants and treatment options, orthodontics, digital imaging technologies, restoratives, endodontics, rotary, infection prevention, and loupes. Envista was formed in 2018 as a wholly-owned subsidiary of Danaher Corporation and completed its initial public offering and separation from Danaher Corporation in 2019. The company serves dental professionals in over 130 countries through its commercial organization and distribution partners. In 2025, Envista generated total sales of $2.7 billion, with approximately 85% derived from sales of consumable products, services, and spare parts. The business operates through two segments: Specialty Products & Technologies, which includes Dental Implant Solutions and Orthodontic Solutions, and Equipment & Consumables, which includes Diagnostic and Consumables Solutions.

Envista Holdings Corp (NYSE:NVST) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 7 items for NVST at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-05, rated 8/10. Across its 7 most recent items scored 7 or higher, the top rating is 9/10, with 7 rated 8 or above. Recent SEC coverage for NVST spans 10-Q, DEF 14A, 10-K, 8-K.

Recent high-impact activity:

  • Envista Beats Q2 Estimates, Lifts 2026 Outlook on Broad-Based Growth
  • Envista Q2 Sales Beat, EPS Surges 58% on Margin Expansion and Tariff Refunds
  • Envista Crushes Q1 Estimates with 14% Sales Growth, Unveils New $300M Share Repurchase
  • Envista Holdings Reports Strong Q1 Earnings, Announces New $300M Stock Repurchase Program
  • Envista Holdings Reports Strong 2025 Financial Turnaround, Details Performance-Based Executive Pay

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$2.72B
Net Income
$47M
Diluted EPS
$0.28
Op. Cash Flow
$275.7M
Free Cash Flow
$230.4M
Gross Profit
$1.49B
Operating Income
$216.1M
Cash & Equivalents
$1.21B
Total Debt
$1.45B
Debt / Equity
0.47×
Net Margin
1.7%
Shares Outstanding
163.8M sh
Source: 10-K · filed 2026-02-12 · accession 0001757073-26-000011

Short Interest & Short Volume

3.97 days to cover

FINRA reported short interest of 10,210,406 shares in NVST as of the September 15, 2026 settlement, a 10.3% decrease from the prior period — about 4.0 days to cover at its recent average daily volume. On October 2, 2026, 62.5% of NVST volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)10,210,406 shares as of September 15, 2026
Change vs prior period▼ 10.3%
Days to cover3.97 at avg daily volume of 2,573,767
Daily short volume (FINRA facilities)62.5% of 938,304 shares on October 2, 2026
5-day average short volume63.4%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with N →
$23.46
52-week range · as of 2026-08-05 $18.77 – $30.42
Market cap
$3.77B
Volume
2.3M (0.9× avg)
3-mo avg 2.7M
Live data · 2026-10-05 03:36 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed NVST - Latest Insights

NVST
Aug 05, 2026, 4:40 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $26.90
Real-time Price: $23.46 info
Change: -$3.44 (-13%) info
Market Cap: $3.768B info
NVST
Aug 05, 2026, 4:20 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $26.90
Real-time Price: $23.46 info
Change: -$3.44 (-13%) info
Market Cap: $3.768B info
NVST
May 06, 2026, 4:48 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $28.92
Real-time Price: $23.46 info
Change: -$5.46 (-19%) info
Market Cap: $3.768B info
NVST
May 06, 2026, 4:18 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $30.11
Real-time Price: $23.46 info
Change: -$6.65 (-22%) info
Market Cap: $3.768B info
NVST
Apr 07, 2026, 4:17 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $25.29
Real-time Price: $23.46 info
Change: -$1.83 (-7%) info
Market Cap: $3.768B info
NVST
Feb 12, 2026, 4:18 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $28.77
Real-time Price: $23.46 info
Change: -$5.31 (-18%) info
Market Cap: $3.768B info
NVST
Feb 05, 2026, 4:11 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $26.25
Real-time Price: $23.46 info
Change: -$2.79 (-11%) info
Market Cap: $3.768B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets